About Us

A world class team of founders, scientists, translational scientists, nutritionists, researchers, doctors, and advisors focused on a single mission: help people live a healthy life.

Leadership Team

Naveen Jain

Founder & CEO

Naveen is an entrepreneur and philanthropist driven to solve the world’s biggest challenges through innovation.

www.naveenjain.com

Guruduth Banavar, PhD

Founding CTO & Head of Discovery AI

Guru is a leader in Artificial Intelligence known for his work on Host/Microbe Molecular Data Analysis, IBM Watson AI Systems, Smarter Cities, Services Innovation, Mobile Computing, and Distributed Systems. As founding CTO at Viome Life Sciences, he leads AI and co-leads clinical research.

Momo Vuyisich, PhD

Founding CSO & Head of Clinical Research

Momo is an entrepreneur-scientist with over 25 years of R&D experience in biology, chemistry, and bioinformatics. He has led large programs, from ideas to successful commercial products.

Stephen Barrie, ND, PhD

VP & Head of Clinical Nutrition

Dr. Barrie is an internationally recognized physician, clinical medical researcher, lecturer, inventor, author, and entrepreneur, and one of the founding pioneers in the microbiome field. He is the founder and former CEO & Chairman of Genova Diagnostics, the world’s largest Functional Medicine clinical reference laboratory for physicians.

John Blanchard

COO

John is an eCommerce and Operations leader who has spent the last 20+ years delivering customer-focused experiences on a global scale. He has a background in computer science, bioinformatics, marketing, supply chain, analytics, operations, and most recently held leadership roles at Amazon and Groupon.

Helene Vollbracht

Head of Brand

Helene joined in 2017 and oversaw Viome's early marketing and product efforts. She now oversees Brand Strategy, PR & Communications, working with marketing and product teams to translate the incredible capabilities of our science and technology into a memorable experience for customers. Her background includes experience in the entertainment & music business, brand marketing, public relations, and behavioral science.

Rodrigo Hutt

VP & GM of Consumer Group

Rodrigo is an entrepreneurial business leader with expertise in scaling emerging businesses, with over 17 years of experience in e-commerce, digital health, and biopharma. He was most recently Country Head, Marketplace VIS at Mercado Libre. Previously, Founder & CEO at VoyalDoc, BU Head Oncology at Pfizer, and Product Marketing at Merck.

Damon Tanton, MD

Chief Medical Officer

Dr. Tanton is an endocrinologist and obesity medicine specialist who oversees the inpatient and outpatient endocrine care across nine clinical campuses. His team conducts over 125,000 patient visits per year, and has been recognized by US News and World Report as one of the top 15 endocrinology programs in the nation. Damon serves as a national strategy consultant and an international speaker on insulin resistance and other metabolic diseases.

Scientific & Business Advisory Board

Stanley Lapidus

Stan Lapidus is an experienced life-science entrepreneur and inventor with over 30 issued U.S. patents. He founded SynapDX, a new company developing diagnostic tests for the early detection of autism, and currently serves as President and CEO. Prior to SynapDX, Stan founded and led Cytyc, EXACT Sciences and Helicos BioSciences, and holds academic appointments at Tufts and MIT.

Alessio Fasano, MD

W. Allan Walker Chair of Pediatric Gastroenterology and Nutrition, Professor of Pediatrics, Harvard Medical School, Chief of Division of Pediatric Gastroenterology and Nutrition.

Andrew McCallum, PhD

Andrew McCallum is Professor and Director of the Information Extraction and Synthesis Laboratory, as well as Director of Center for Data Science in the College of Information and Computer Science at University of Massachusetts Amherst.

Salomon Amar, D.D.S., Ph.D.

Salomon Amar, D.D.S., Ph.D., is vice president for research at New York Medical College and director of the office of research administration. Dr. Amar holds academic appointments as professor of pharmacology and professor of microbiology and immunology at NYMC.

George Church, PhD

George is Professor of Genetics at Harvard Medical School and Professor of Health Sciences and Technology at Harvard and the Massachusetts Institute of Technology (MIT). He is Director of the U.S. Department of Energy Technology Center and Director of the National Institutes of Health Center of Excellence in Genomic Science.

Umadevi Naidoo, MBCHB

Umadevi the Director of Nutritional and Metabolic Psychiatry at Massachusetts General Hospital & Director of Nutritional Psychiatry at the MGH Academy while serving on the faculty at Harvard Medical School.

Ed Zuckerberg, DDS, FAGD

Dr. Edward Zuckerberg has been a pioneer in the integration of technology in the dental office and development of techniques for delivering painless dentistry for over 30 years. He continues the advancement of newer dental technologies through lecturing at dental conferences and conventions.

Sanjiv Chopra, MD

Sanjiv Chopra, MD, is a Professor of Medicine and served as Faculty Dean for Continuing Medical Education at Harvard Medical School for 12 years. He serves as a Marshall Wolf Master Clinician Educator Brigham and Women’s Hospital.

Board of Directors

Naveen Jain

Founder & CEO

Naveen is an entrepreneur and philanthropist driven to solve the world’s biggest challenges through innovation.

www.naveenjain.com

Erik Anderson

Erik Anderson is a leader in global innovation recognized throughout his career for his business acumen and leadership. As the Founder and Chief Executive Officer of WestRiver Group (WRG), Anderson is redefining the paradigm of capital allocation with a transformative business model.

Chris Kitze

Chris Kitze is a technology innovator and investor. As a serial entrepreneur, he has created companies with over $7 billion of market capitalization during a 25-year career. He was part of the Lycos’ IPO team, and founder and CEO of Xoom.com (IPO: 1998), and was CEO of NBCi, formed by the merger of Xoom.com and Snap.com, in addition to other companies in digital communications, media and payments.

Bill Owens

Former Vice-Chairman of the Joint Chief of Staff of the United States of America, CEO of Nortel Telecommunications, Vice-Chairman for NYSE Asia, and Chairman and Senior Partner of AEA Investors Asia. Admiral Owens was also Chairman of Eastern Airlines and served on over 25 public boards including Daimler, British American Tobacco, Telstra, Nortel Networks, and Polycom.

Eiichiro Kimura

Dr. Eiichiro Kimura has led business development in Japan-based global Food & Nutrition companies, such as Ezaki Glico and Ajinomoto, over 30 years. He worked in the Cabinet Office of the Japanese Government to establish strategy for Life Sciences. He was Board of Directors and Executives in biotech companies in Japan, US and Russia. He has a background in molecular biology, clinical nutrition, technology management, and open innovation.

Steve Sansom

Steve Sansom is a serial entrepreneur in the financial services industry and investor. As a serial entrepreneur, he created several companies including Center Coast Capital as well as Green Square Capital and Convergence Value Partners. He was the former Vice Chairman of the International Board of the Young Presidents Organization and currently sits on the board of the Chief Executives Organization and several company boards in the private equity, fintech, financial services, and healthcare industries.

Investors

“Viome is rapidly scaling to become a global leader in the longevity space, to promote better health outcomes today and our future generations, with exceptional innovation. The Viome team continues to accelerate leading AI-driven techniques to analyze gut microbiome data, which is leading to breakthrough new discoveries to benefit all of mankind.”

Harish Consul, Founder & CEO, Ocgrow Ventures

“The future of healthcare is individual and personalized, and few companies have been driving innovation in this space as rapidly as Viome. Through the company’s continued research, development, and advancements, Viome is bringing us one step closer to a healthier world.”

Vinod Khosla, Founder & CEO of Khosla Ventures

"I am impressed by Viome’s unparalleled ability to produce high-quality insights from both the microbiome and human cells. This allows Viome to understand the underlying reasons for a range of biological reactions and make food & supplement recommendations whose goal is to promote and maintain optimal health."

Alessio Fasano, Professor and Director of the Mucosal Immunology and Biology Research Center at Massachusetts General Hospital

"Viome is breaking new ground in developing precision recommendations of foods and supplements, and studying how these interventions can improve a range of biological processes, especially related to digestion and mood. They are not only discovering the mechanisms underlying human health, but also developing new methods for improving health through the use of precision supplements."

Emeran Mayer, Physician-scientist, UCLA Professor of Medicine, Physiology and Psychiatry